Most Recent Additions*
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
Fabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, Priyanka Shailendra Rana, Elzbieta Pluskota, Pyung Hun Park, Christopher D Shields, Stephen Lin, Peter McCue, Andrew V Kossenkov, Yanqing Wang, David W Goodrich, Sheng-Yu Ku, Himisha Beltran, William K Kelly, Eva Corey, Maja Klose, Christine Bandtlow, Qin Liu, Dario C Altieri, Edward F Plow, and Lucia R Languino
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers.
Zachary T Elliott, Zachary Goldberg, Ramez Philips, Jennifer M Johnson, Margaret T Kasner, William K Kelly, Sarah Osipowicz, Rachael Dampman, and Joseph M Curry
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.
Brittiny Dhital, Sandra Santasusagna, Perumalraja Kirthika, Michael Xu, Peiyao Li, Marc Carceles-Cordon, Rajesh K Soni, Zhuoning Li, Ronald C Hendrickson, Matthew J Schiewer, William K Kelly, Cora N Sternberg, Jun Luo, Amaia Lujambio, Carlos Cordon-Cardo, Monica Alvarez-Fernandez, Marcos Malumbres, Haojie Huang, Adam Ertel, Josep Domingo-Domenech, and Veronica Rodriguez-Bravo
Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer.
Diana C Simão, Kevin K Zarrabi, José L Mendes, Ricardo Luz, Jorge A Garcia, William K Kelly, and Pedro C Barata
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
Susan Halabi, Qian Yang, Akash Roy, Bin Luo, John C Araujo, Christopher Logothetis, Cora N Sternberg, Andrew J Armstrong, Michael A Carducci, Kim N Chi, Johann S de Bono, Daniel P Petrylak, Karim Fizazi, Celestia S Higano, Michael J Morris, Dana E Rathkopf, Fred Saad, Charles J Ryan, Eric J Small, and William Kevin Kelly
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer.
James Fradin, Felix J Kim, Grace L Lu-Yao, Eugene Storozynsky, and William K Kelly
Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer.
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Jeffrey Karnes, Karen E Knudsen, Carlos Cordon-Cardo, Haidong Dong, Haojie Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, and Josep Domingo-Domenech
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer.
Kevin K Zarrabi, Vivek Narayan, Patrick J Mille, Matthew R Zibelman, Benjamin Miron, Babar Bashir, and William Kevin Kelly
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
William K Kelly, Daniel C Danila, Chia-Chi Lin, Jae-Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David Pook, Miso Kim, Tanya B Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian L Penny, Julia Stieglmaier, and Leonard J Appleman
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
Zhenchao Zhang, Rui Luo, William K Kelly, Joshua Chen, Shane Donahue, Kevan Ip, Nathan R Handley, William J Tester, Miranda L Tsang, Felix J Kim, Ronald Myers, Grace Lu-Yao, Jian Gu, Jianqing Lin, Bingshan Li, Chun Wang, and Hushan Yang
Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
Anna Testa, Fabio Quaglia, Nicole M Naranjo, Cecilia E Verrillo, Christopher D Shields, Stephen Lin, Maxwell W Pickles, Drini F Hamza, Tami Von Schalscha, David A Cheresh, Benjamin Leiby, Qin Liu, Jianyi Ding, William K Kelly, D Craig Hooper, Eva Corey, Edward F Plow, Dario C Altieri, and Lucia R Languino
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-
Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O'Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L McLeod, Mark J Ratain, Andrew B Nixon, Federico Innocenti, and Kouros Owzar
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).
Jai N Patel, Chen Jiang, Kouros Owzar, Daniel L Hertz, Janey Wang, Flora A Mulkey, William K Kelly, Susan Halabi, Yoichi Furukawa, Cameron Lassiter, Susan G Dorsey, Paula N Friedman, Eric J Small, Michael A Carducci, Michael J Kelley, Yusuke Nakamura, Michiaki Kubo, Mark J Ratain, Michael J Morris, and Howard L McLeod
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
Stacy Loeb, Scott W Keith, Heather H Cheng, Amy E Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne, Rebecca Hartman, Lauren H Brown, Christopher Michael Pieczonka, Leonard G Gomella, William Kevin Kelly, Costas D Lallas, Nathan Handley, Patrick Johnston Mille, James Ryan Mark, Gordon Andrew Brown, Sameer Chopra, Alexandra McClellan, David R Wise, Lucas Hollifield, and Veda N Giri
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Julia C F Quintanilha, Alexander B Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O'Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L McLeod, Mark J Ratain, Andrew B Nixon, Federico Innocenti, and Kouros Owzar
Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma.
Nicole M Naranjo, Anne Kennedy, Anna Testa, Cecilia E Verrillo, Adrian D Altieri, Rhonda Kean, D Craig Hooper, Jindan Yu, Jonathan Zhao, Oliver Abinader, Maxwell W Pickles, Adam Hawkins, William K Kelly, Ramkrishna Mitra, and Lucia R Languino
Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension.
Julia C F Quintanilha, William Kevin Kelly, and Federico Innocenti
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.
Channing J Paller, Marianna L Zahurak, Adel Mandl, Nicole A Metri, Aliya Lalji, Elisabeth Heath, William K Kelly, Christopher Hoimes, Pedro Barata, Jason Taksey, Dominique A Garrison, Kartick Patra, Ginger L Milne, Nicole M Anders, Julie M Nauroth, Jennifer N Durham, Catherine H Marshall, Mark C Markowski, Mario A Eisenberger, Emmanuel S Antonarakis, Michael A Carducci, Samuel R Denmeade, and Mark Levine
Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2.
Cecilia E Verrillo, Fabio Quaglia, Christopher D Shields, Stephen Lin, Andrew V Kossenkov, Hsin-Yao Tang, David Speicher, Nicole M Naranjo, Anna Testa, William K Kelly, Qin Liu, Benjamin Leiby, Luca Musante, Khalid Sossey-Alaoui, Navneet Dogra, Tzu-Yi Chen, Dario C Altieri, and Lucia R Languino
Irradiation of prostate cancer alters circulating small extracellular vesicle functions.
Aejaz Sayeed, Vaughn Garcia, Cecilia E Verrillo, Rachel M DeRita, Md Niamat Hossain, Shiv Ram Krishn, Samuel Sey, Christopher D Shields, Adrian D Altieri, Qin Liu, Khalid Sossey-Alaoui, William K Kelly, and Lucia R Languino
*Updated as of 08/06/26.